Additional gut-derived markers, including lipopolysaccharide-binding protein (LBP), soluble CD14 (sCD14), and calprotectin, were numerically increased in eALD but did not reach statistical significance.
← all excerpts
Illustration of the gut-immune-liver axis in early-stage alcohol-related liver disease: role and non-invasive potentiation of biomarkers and peptidomic signatures.
1
—
—